IL6ST and gastric cancer: The findings also paved the way for individualized postoperative adjuvant chemotherapy based on different intratumoral gp130 expression, in that TNM II/III, gp130-high gastric cancer patients could significantly benefit from 5-FU based adjuvant chemotherapy.